Female cystic fibrosis mutation carriers and assisted reproductive technology: does carrier status affect reproductive outcomes?

2014 ◽  
Vol 102 (5) ◽  
pp. 1324-1330 ◽  
Author(s):  
Teresa A. VanWort ◽  
Joseph A. Lee ◽  
Hrishikesh Karvir ◽  
Michael C. Whitehouse ◽  
Piraye Yurttas Beim ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Assisted Reproductive Technology ◽  
Reproductive Technology ◽  
Carrier Status ◽  
Reproductive Outcomes ◽  
Cystic Fibrosis Mutation ◽  
Mutation Carriers

scholarly journals Effect of follicular flushing on reproductive outcomes in patients with poor ovarian response undergoing assisted reproductive technology

2017 ◽  
Vol 34 (10) ◽  
pp. 1353-1357 ◽  
Author(s):  
Anna L M Souza ◽  
Marcos Sampaio ◽  
Graciele B Noronha ◽  
Ludiana G R Coster ◽  
Roberta S G de Oliveira ◽  
...  
Keyword(s):  
Assisted Reproductive Technology ◽  
Ovarian Response ◽  
Reproductive Technology ◽  
Reproductive Outcomes ◽  
Poor Ovarian Response

scholarly journals Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?

2020 ◽  
Vol 24 (22) ◽  
pp. 13542-13545
Author(s):  
Panagiotis Sarantis ◽  
Evangelos Koustas ◽  
Athanasios G. Papavassiliou ◽  
Michalis V. Karamouzis
Keyword(s):  
Cystic Fibrosis ◽  
Cystic Fibrosis Mutation ◽  
Vulnerable Group ◽  
Mutation Carriers

scholarly journals Cystic fibrosis heterozygosity does not impact ovarian reserve or assisted reproductive technology outcomes

2019 ◽  
Vol 111 (4) ◽  
pp. e23-e24
Author(s):  
L. Sekhon ◽  
Z. Luscher ◽  
T.A. Cacchione ◽  
J.A. Lee ◽  
T. Mukherjee ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Assisted Reproductive Technology ◽  
Ovarian Reserve ◽  
Reproductive Technology
Sign in / Sign up

Export Citation Format

Share Document